• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗与功能性抗体的诱导:是时候超越自然感染的分子层面去探寻了吗?

Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?

作者信息

Burton D R, Parren P W

机构信息

Department of Immunology and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.

出版信息

Nat Med. 2000 Feb;6(2):123-5. doi: 10.1038/72200.

DOI:10.1038/72200
PMID:10655088
Abstract

Infection with some pathogens induces weak functional antibody responses that are non-protective, and there has been some skepticism about a role for antibodies in vaccine design. However, newer data show that antibodies can protect against infection with these pathogens, and new methods to elicit production of functional antibodies should be sought.

摘要

感染某些病原体可诱导产生微弱的、无保护作用的功能性抗体反应,并且对于抗体在疫苗设计中的作用一直存在一些怀疑。然而,最新数据表明抗体可以预防这些病原体的感染,因此应该寻找引发功能性抗体产生的新方法。

相似文献

1
Vaccines and the induction of functional antibodies: time to look beyond the molecules of natural infection?疫苗与功能性抗体的诱导:是时候超越自然感染的分子层面去探寻了吗?
Nat Med. 2000 Feb;6(2):123-5. doi: 10.1038/72200.
2
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.一种佐剂多蛋白重组疫苗在未感染人类志愿者中引发的持久HIV-1抗体和T细胞反应。
Vaccine. 2007 Jan 5;25(3):510-8. doi: 10.1016/j.vaccine.2006.07.050. Epub 2006 Aug 10.
3
HIV vaccine design and the neutralizing antibody problem.HIV疫苗设计与中和抗体问题。
Nat Immunol. 2004 Mar;5(3):233-6. doi: 10.1038/ni0304-233.
4
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.表达与C3d融合的可溶性CD4包膜蛋白的DNA疫苗可引发针对HIV-1的交叉反应性中和抗体。
Virology. 2004 Oct 25;328(2):292-300. doi: 10.1016/j.virol.2004.07.031.
5
Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins.限制HIV-1 gp120包膜糖蛋白免疫原性的因素。
Virology. 2004 Dec 5;330(1):233-48. doi: 10.1016/j.virol.2004.08.037.
6
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial.在一项3期HIV-1预防性疫苗试验中,重组糖蛋白120疫苗的免疫反应与HIV-1感染发生率之间的相关性。
J Infect Dis. 2005 Mar 1;191(5):666-77. doi: 10.1086/428405. Epub 2005 Jan 27.
7
Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.恒河猴体内HIV-1 gp120诱导的免疫反应评估:疫苗接种对同源和异源猿猴人类免疫缺陷病毒致病株攻击的影响。
Virology. 2000 Aug 15;274(1):149-64. doi: 10.1006/viro.2000.0444.
8
Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.重组E亚型和B亚型1型人类免疫缺陷病毒包膜糖蛋白120疫苗组合在泰国健康成年人中的安全性和免疫原性。
J Infect Dis. 2003 Jul 15;188(2):219-27. doi: 10.1086/376506. Epub 2003 Jul 3.
9
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.感染早期的HIV-1 A亚型包膜变体对中和作用以及病毒进入抑制剂具有不同的敏感性。
AIDS. 2007 Mar 30;21(6):693-702. doi: 10.1097/QAD.0b013e32805e8727.
10
Controversial HIV vaccine enters phase III trials amid skepticism.备受争议的艾滋病疫苗在质疑声中进入三期试验。
AIDS Alert. 1998 Dec;13(12):133-4, 136.

引用本文的文献

1
Subdominance in Antibody Responses: Implications for Vaccine Development.抗体反应中的次优势性:对疫苗开发的影响。
Microbiol Mol Biol Rev. 2020 Nov 25;85(1). doi: 10.1128/MMBR.00078-20.
2
The HIV-1 Envelope Glycoprotein C3/V4 Region Defines a Prevalent Neutralization Epitope following Immunization.HIV-1 包膜糖蛋白 C3/V4 区在免疫接种后定义了一个普遍存在的中和表位。
Cell Rep. 2019 Apr 9;27(2):586-598.e6. doi: 10.1016/j.celrep.2019.03.039.
3
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.
模拟CD4结合位点的抗独特型单克隆抗体在兔体内引发的抗HIV-1反应。
PLoS One. 2008;3(10):e3423. doi: 10.1371/journal.pone.0003423. Epub 2008 Oct 16.
4
A simple one-step method for the preparation of HIV-1 envelope glycoprotein immunogens based on a CD4 mimic peptide.一种基于CD4模拟肽制备HIV-1包膜糖蛋白免疫原的简单一步法。
Virology. 2008 Nov 25;381(2):241-50. doi: 10.1016/j.virol.2008.08.039. Epub 2008 Oct 2.
5
Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.表达两个拷贝狂犬病病毒糖蛋白基因的磷蛋白缺失狂犬病病毒疫苗载体的免疫调节作用
Vaccine. 2008 Nov 25;26(50):6405-14. doi: 10.1016/j.vaccine.2008.08.069. Epub 2008 Sep 18.
6
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.一项关于携带各种形式包膜蛋白的HIV-1病毒样颗粒、无包膜颗粒和可溶性单体gp120的比较免疫原性研究。
Virology. 2007 Sep 30;366(2):245-62. doi: 10.1016/j.virol.2007.04.033. Epub 2007 Jun 19.
7
Anticandidal immunity and vaginitis: novel opportunities for immune intervention.抗念珠菌免疫与阴道炎:免疫干预的新机遇
Infect Immun. 2007 Oct;75(10):4675-86. doi: 10.1128/IAI.00083-07. Epub 2007 Jun 11.
8
Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.1型人类免疫缺陷病毒对高甘露糖结合剂氰苷菌素N和伴刀豆球蛋白A的耐药性。
J Virol. 2005 Jun;79(12):7777-84. doi: 10.1128/JVI.79.12.7777-7784.2005.
9
Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes.共价连接的人类免疫缺陷病毒1型gp120/gp41稳定锚定在弹状病毒颗粒中,并暴露关键中和表位。
J Virol. 2003 Dec;77(23):12782-94. doi: 10.1128/jvi.77.23.12782-12794.2003.
10
Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.在猫体内持续存在7年的一株猫免疫缺陷病毒中,两个决定广泛中和抗性的氨基酸位点的演变。
Clin Diagn Lab Immunol. 2003 Nov;10(6):1109-16. doi: 10.1128/cdli.10.6.1109-1116.2003.